Group 1 - The core viewpoint of the news is that Dailong (002209.SZ) has seen an increase in institutional investor holdings, indicating growing confidence in the company [1] - As of August 21, 2025, 22 institutional investors disclosed holding a total of 37.93 million shares of Dailong, accounting for 19.06% of the total share capital [1] - The top ten institutional investors collectively hold 18.84% of the shares, with their combined holding ratio increasing by 5.07 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two public funds increased their holdings, accounting for 1.34% of the total [2] - A total of 18 new public funds were disclosed compared to the previous quarter, including several notable funds such as Huaxia Ruipan Taili Mixed A and the Southern CSI 500 Quantitative Enhanced Stock Initiation A [2] - One new foreign institution, UBS AG, was disclosed this quarter, while Morgan Stanley & Co. International PLC was not disclosed in the current period [2]

7月15日，联环药业股票盘中跌停，江苏联环药业股份有限公司诞生于1999年12月,由成立于1958年的扬州制药厂发起创建,是一家集研发、生产、销售为一体 的国家高新技术企业。 财报显示，招商基金旗下2只基金进入联环药业前十大股东，持股比例为0.88%。其中招商量化精选股票A今年一季度增持，招商成长量化选股股票A今年一 季度新进。 其中，招商量化精选股票A今年以来收益率20.03%，同类排名138(总992)，招商成长量化选股股票A今年以来收益率15.45%，同类排名229(总992)。 | 阶段涨幅 | 季度涨幅 年度涨幅 | 今年以米合阶段业绩及同关排名 | | 4 下载天天基金手机版,随时查 | | | --- | --- | --- | --- | --- | --- | | | 近1周 | 近1月 | 近3月 | 近6月 | 今年来 | | 阶段涨幅 | 3.04% | 8.72% | 18.0696 | 21.12% | 20.03 | | 同类平均0 | 1.74% | 4.17% | 8.98% | 11.69% | 10.10 | | 沪深300 | 0.52% | 4.01% | 6.85% ...